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Editorial: A New Perspective 
Laura Hinz BSc (Meds 2011) 
A stack of Canadian Medical 
Association Journals (CMAJ) sits on my 
kitchen table.  I have big plans to read and 
understand each article, to expand my 
knowledge, to feel like a real doctor.  But 
more often than not those CMAJs simply 
serve as a place mat for the novel or 
newspaper that I lay over top.  It is always 
with a twinge of guilt that I delay reading 
these journals.  It feels like they are 
something I should read, that I have a 
responsibility to read.  This guilt is made all 
the more poignant by the question that 
always seems to accompany my decision to 
leave the CMAJ closed- why don’t I want to 
read it?  Didn’t I spend the better part of the 
last decade doing everything I could to get 
into medical school?  Didn’t I experience an 
almost embarrassing level of excitement 
when that first issue was delivered to my 
mailbox?      
That question has nettled me all year 
as the stack grew ever taller.  But this 
summer my clinical elective preceptor 
helped me to answer that question.  She said 
that the CMAJ isn’t necessarily relevant to 
me at this point in my training.  We simply 
haven’t learned enough to either completely 
understand every article nor to find it always 
interesting.  Much like a book on skydiving 
would be mildly intriguing to an earth-
bound reader, it doesn’t become riveting 
until you’ve taken that first leap.  This 
summer, many of our classmates leapt for 
the first time.  We left behind our textbooks 
and lectures and faced the real world of 
medicine. 
The Summer Supplement is a record 
of those experiences in the real world.  This 
issue of the UWOMJ is considerably 
different from the regular print issues.  The 
purpose of the articles in this issue is not just 
to inform, but to inspire and celebrate.  
These are the true experiences of our 
classmates; they remind us of our own 
summer experiences, encourage us to move 
beyond the familiar, and commemorate the 
successes of our peers.  By capturing these 
experiences in an article for the Summer 
Supplement, we are able to leave a record of 
all the things we accomplished this summer, 
be it research, clinical electives, or travel. 
In addition to different goals, the 
perspective of this issue is remarkably 
different.  Normally the authors’ gaze is in 
to the literature; the Summer Supplement 
has challenged us to raise our eyes up from 
our textbooks, beyond the walls of our 
classrooms and to see how medicine exists 
in the real world.  This perspective is 
simultaneously exciting, overwhelming, and 
inspiring.  Suddenly we saw that diseases 
that were described in our notes happen to 
real people, and it is now up to us to dredge 
up all the facts that we painstakingly learned 
throughout the year and apply them to actual 
practice. 
   UWOMJ 78(1) 2008 S2 
 
A written discourse tells the world 
how you want to be remembered.  It is a 
record of your thoughts and perceptions, 
your level of knowledge, your interests.  
That is what makes this issue of the 
UWOMJ different from the regular print 
issues and from publications like the CMAJ.  
This compilation of articles is all about 
perspective.  Authors were encouraged to 
write an article that would appeal to the 
medical student, both in terms of knowledge 
level and interest.  While the goal was also 
to describe common presentations, 
diagnostic tools, and treatments, the primary 
aim of this issue was to create a record of 
medicine through the eyes of the Classes of 
2010 and 2011. 
It is immediately apparent that each 
article in this collection has a slightly 
different structure.  The reason is that the 
authors were encouraged to be creative.  
Since perspective plays such a pivotal role in 
this collection, each author was encouraged 
to choose a style that worked for their topic, 
their case, their style of writing. 
Given this emphasis on perspective, I 
hope this collection of articles will not suffer 
the same fate as my CMAJs.  The 
subsequent articles are each relevant to this 
point of our education, simply by virtue of 
the fact that they were written by members 
of the intended audience.  The diverse 
compilation that follows will hopefully help 
you to broaden your perspective, to consider 
medicine as an entity outside of the 
classroom, and to inspire you to approach 
your studies in such a way that will prepare 
you for your own leap into the real world of 
medicine. 
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Figure 1. Delta prosthesis used for reverse total 
shoulder arthroplasty. 
http://www.jnjgateway.com/home.jhtml 
Right Total Shoulder Replacement with Reverse Delta 
Prosthesis, Complicated by a Brachial Plexus Injury 
 
Amin Madani, Hon. BSc. (Meds 2011), Dr. Richard M. Holtby, MD, MB, BS, FRCSC 
 
Abstract/Introduction 
 
When conventional total shoulder 
replacements are not considered to be an 
effective surgical management to 
improve patients’ quality of life, a 
reverse total shoulder arthroplasty is 
considered.  The reverse total shoulder 
replacement is where a prosthesis with a 
convex articular surface is fixed to the 
lateral aspect of the glenoid, and a 
prosthesis with a concave articular 
surface is fixed to the proximal aspect of 
the humerus (Figure 1).1  This procedure 
was initially indicated for patients with 
rotator cuff arthropathy, for whom a 
traditional total shoulder replacement 
has a relatively high rate of failure.1,2   
 
Today, they are also indicated for 
patients with failed arthroplasty, or for 
selected patients with shoulder fractures 
whose prosthesis has failed.3   Despite its 
high success rate, this procedure is also 
prone to complications.1,2,3,4  It is 
estimated that 1-4% of shoulder 
arthroplasty cases produce neurologic 
complications.1,2  In this type of patient 
who has a history of rotator cuff 
arthropathy and a full-thickness rotator 
cuff tear that was repaired and 
subsequently degenerated, it is shown 
that a total shoulder arthroplasty with a 
reverse prosthesis can be used to provide 
improved function and quality of life.  It 
is furthermore shown that patient 
recovery and functional outcome can be 
complicated by radial nerve palsy. 
 
Case 
 
Mrs. W is a 74-year-old woman 
seen in the clinic for assessment of her 
right shoulder.  She has a thirteen-year 
history of pain, where she was diagnosed 
with a rotator cuff tear and had surgical 
repair nine years ago.  Although she felt 
this helped significantly, there was 
gradual increase in pain and weakness of 
the shoulder.  Examination showed that 
she was able to get her arm to 150o of 
flexion with some catching and pain.  
External rotation was 45o with internal 
rotation to the thoracolumbar junction.  
She had pain, crepitus coming from the 
subacromial space, and significant 
weakness of forward flexion.  X-rays 
were also done, which showed 
degenerative changes at the 
glenohumeral joint with marked superior 
migration of the humeral head with 
respect to the glenoid fossa, consistent 
with rotator cuff arthropathy. 
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Rotator cuff arthropathy is 
characterized by irreparable loss of the 
rotator cuff, severe osteoarthritis of the 
glenohumeral joint, pain, and minimal 
function of the shoulder.1,2,3  It was felt 
that a reverse prosthesis would not only 
effectively help her pain and provide 
more function, but unlike the traditional 
shoulder replacements, would resist 
superior translation of the humeral head 
due to a lack of stability of the joint from 
degeneration of the supraspinatus rotator 
cuff muscle. 
 
Surgical Technique 
 
The shoulders were examined 
with the patient under general 
anaesthesia, where the range of motion 
of the right side was noted to be sub-
optimal (Table 1). 
 
Table 1. Pre-Operative Range of 
Motion of the Right Shoulder 
Forward Flexion 150o 
Abduction 90o 
External Rotation (with 0o 
abduction) 
40o 
External Rotation (with 90o 
abduction) 
40o 
Internal Rotation (with 90o 
abduction) 
20o 
 
With the patient in the beach 
position, draping was done to expose the 
shoulder with the arm free, allowing the 
surgeon and his assistants to manoeuvre 
the arm in different positions.  The 
incision was a saber-cut incision, which 
is made 4 cm from the superior border of 
the anterior and middle deltoid fibers, 
passing just above the acromioclavicular 
joint, extending 5 cm inferiorly on the 
posterior side and creating a reverse U-
shape.1,2  A deep deltoid incision was 
subsequently done to get access to the 
joint.  Operative findings included a 
massive rotator cuff tear of the 
supraspinatus estimated at 5 cm medial 
to lateral and 5 cm anterior to posterior, 
bone erosion and eburnation of bone on 
the articular surface of the humeral head 
and glenoid consistent with 
osteoarthritis, degeneration of 
subscapularis and teres minor muscles, 
and rupture of the long head of the 
biceps tendon. 
 
Initial neck cut was made 
removing the head component at the 
surgical neck of the humerus, providing 
exposure of the glenoid with a fork 
retractor.  The capsule was then released 
around the articular margins, and the 
labrum and biceps tendon remnant 
removed.  Once the centre of the glenoid 
was demarcated, a drill hole was made 
into the glenoid medullary cavity.  This 
allowed the insertion of the glenosphere 
reamer and metaglene (glenoid 
components of the prosthesis), which 
were hammered into place, and fixated 
with four screws. 
 
After drilling a canal for the 
humeral component’s stem, trial humeral 
components were inserted to determine 
the correct size of the prosthesis.  After 
appropriate trial reductions, the canal 
was prepared for irrigation, filled with 
cement, and the humeral stem cemented 
into place.  Finally, the definitive 
glenosphere and humeral polyethylene 
components were inserted, and the joint 
reduced, which showed stability with 
good range of motion.  After a routine 
closure, the patient returned to the 
recovery room with a simple blue sling 
and in satisfactory condition.  Ancef was 
given as prophylactic antibiotic with two 
doses given intra-operatively. 
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Post-Operative Results and Discussion 
 
Specimen sent with fragments of 
bone and soft tissues from the joint, as 
well as post-operative x-rays revealed no 
apparent complications (Figure 2). 
However, the day following surgery she 
was noted to have a right finger and 
wrist drop with numbness in the 
posterior arm, despite regaining 
significant range of shoulder movement.  
Examination revealed absent right 
brachioradialis and triceps reflex with 
normal biceps reflex.  There was marked 
weakness of right shoulder external 
rotation and abduction, almost no triceps 
function, no visible brachioradialis 
function and only slight wrist extension 
with total finger drop.  Sensation to pin 
was also reduced in the posterior hand, 
forearm and upper arm.   
 
 
Figure 2. Example of a post-operative 
anteroposterior radiograph from a 
reverse total shoulder arthroplasty.1 
 
Electromyography workup 
showed normal right median and ulnar 
nerve conduction.  The radial sensory 
response was absent and lateral 
cutaneous nerve of forearm normal.  
Needle electrode examination revealed 
marked and moderate denervations of 
the infraspinatus and deltoid muscles, 
respectively, and severe denervation 
throughout the radial nerve distribution.  
Although musculocutaneous, median 
and ulnar nerve function were normal, 
there was partial denervation in 
suprascapular, axillary and mostly radial 
nerve distribution.  As there were some 
surviving neurons, the nerves appeared 
to be in continuity but with axonal 
deterioration.  It is likely that the lesion 
was at the border of the teres muscle or 
more proximally in the superior trunk.  
With severe axonal loss in the radial 
nerve distribution, recovery proceeded 
slowly over a number of months with 
appropriate physiotherapy, and the 
patient eventually regained brachial 
plexus function with total reinnervation. 
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The Consequences of Poorly Controlled Diabetes in a Young 
First Nations Man 
Dax Biondi, BSc, MSc (Meds 2011) and Dr. Michael Kirlew, Northern Medical Practice, 
Meno Ya Win Health Centre, Sioux Lookout
The consequences of poorly 
controlled diabetes, including blindness and 
renal failure, are exemplified in a young 
man from an isolated Northwestern Ontario 
community. The nurse in charge reported 
during the summer of 2008 that 25% of 
community members have diabetes. There 
are many social and medical reasons for a 
patient’s failure to control his or her blood 
glucose. The claim that financial barriers 
prevent First Nations people from eating a 
diet that is high in fruits and vegetables, 
complex carbohydrates and protein and low 
in fat and sugar is addressed in the present 
study. It is well known that morbidity can 
result from poorly controlled diabetes; 
Derek’s story sadly illustrates its devastating 
toll. 
Derek is 27 this year but as Dr. 
Michael Kirlew mentioned, chronic poor 
diabetes control has aged his blood vessels 
to the equivalent of 47 years. Dr. Kirlew is a 
family physician, one of several who has 
provided care for Derek since he was 
diagnosed with type II diabetes mellitus at 
the age of 13. His sister, who also has 
diabetes as do Derek’s mother and all his 
maternal aunts, has taken care of him for the 
last 3 years. Derek worked in renovations in 
his community until diabetic complications 
rendered him incapable. Clinic notes over 
the past 3 years detail the toll that high blood 
glucose has taken on Derek’s body. Despite 
consistent medical advice and support, 
Derek has failed to accept the invitation to 
become involved in the management of his 
disease. At such a young age, his condition 
is now nearly palliative. 
The backbone of type II diabetes 
management is well-controlled blood 
glucose; maintaining hemoglobin 
glycosylation below 7% is protective against 
microvascular complications1. It is not 
surprising that it was difficult to convince a 
rebellious 17 year old of the potential 
consequences of his disease. As a teenager, 
Derek felt fine and in the absence of 
consistent family support, Derek did not 
attend most of his diabetes education 
classes. Free of charge, he was given the 
opportunity to attend education camps and 
counseling but he did not take advantage. 
Five years later, at the age of 22, Derek’s 
doctor dictated a letter to Derek’s boarding 
school principal. His doctor urged the 
principal to assist Derek with his blood 
glucose control as its high levels where 
likely impairing his ability to study. The 
proportion of HbA1c that is glycosylated 
reflects what a patient’s average blood 
glucose has been over the proceeding 3 
months2. Figure 1 illustrates that the 
glycosylation of Derek’s HbA1c between 
2006 and 2008 was consistently elevated. 
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Fi
Fgure 1.  Derek’s HbA1c measurements taken over 2 years demonstrate that his blood sugar was 
consistently toxically elevated. 
Pharmacotherapy of Derek’s disease 
floundered. At 23 years, he was supposed to 
be taking Glyburide, Metformin and insulin 
to control his blood sugar. However, Derek 
was forgetting to take his Glyburide and he 
chose to stop taking his Metformin when an 
increase in dose began to cause him 
gastrointestinal upset. Shortly after, he 
developed diabetic foot ulcers due to 
neuropathy that rendered his feet less 
sensitive. Yet, his feet were found to have 
good pulses, colour and sensation and 
fortunately, his ulcers were not infected. It 
was assumed that his ulcers were due to 
wearing work boots. 
At 24 years, Derek began to 
appreciate the gravity of his disease and was 
willing to take insulin. However, 11 years of 
poorly controlled diabetes had already 
damaged his kidneys and urinalysis 
indicated that there was protein in his urine. 
He reported at that time that he did not drink 
any alcohol nor take any illegal drugs. 
Around 25 years, Derek discontinued 
taking his insulin and Glyburide and made it 
known he did not care to check his blood 
sugar at home. This coincided with the onset 
of infected foot ulcers for which treatment in 
Sioux Lookout, a community 400km to the 
south, had to be sought.  Diabetes is a 
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vascular disease and necessitates 
cardiovascular protective pharmacotherapy. 
Despite blood pressures as high as 165/102, 
we cannot be certain this 25 year old was 
taking his Ramipril regularly.  
Almost 13 years of nearly 
subclinical, consistently high blood glucose 
levels began to show evidence of destruction 
during Derek’s 26th year.  At an appointment 
in which his morning blood glucose was 
found to be 15 mmol/L and post lunch, 16-
18, he stated that he had blurred vision and 
bilateral decrease in sensation below the 
knees. Despite these symptoms, he failed to 
attend an appointment with an 
ophthalmologist in the city of Winnipeg 
because he did not qualify for an escort. 
Given that escorts are an important part of 
care for patients in isolated communities, the 
government pays for the cost of 
transportation for a friend or family member 
to travel to one of the regional centres to 
enable the patient to access required care. 
Derek was frustrated that he did not qualify 
for such a companion and for that reason, he 
missed his appointment. 
About a month after missing the 
ophthalmology appointment, Derek 
presented with a fixed dilated pupil due to a 
dense vitreous hemorrhage of his right eye; 
this caused neovascular glaucoma, which 
rendered that eye blind. Shortly thereafter, 
he developed bilateral diabetic peripheral 
neuropathy and diffuse eczema on his lower 
legs, presumably from venous stasis. In the 
fall of that year, he began to experience 
tunnel vision in his left eye and further tests 
indicated proteinuria. 
I had the opportunity to meet Derek 
in his home clinic this past summer. At 27 
years of age, he presented with leg pain that 
was not responding to Tylenol Number 3. 
He had a large ulcer on the dorsum of his 
right foot, for which his doctor was 
concerned about underlying osteomyelitis. 
He had a deep vein saddle thrombosis, 
which arched from his right femoral vein to 
his left and he was in kidney failure. He was 
blind and he could no longer walk.  
To facilitate dialysis, Derek will 
move to Thunder Bay in the near future. He 
is aware of the irreversible toll that high 
blood glucose has taken on his body and he 
is trying to prepare himself for the 
consequences.  
Many social and medical factors 
have contributed to Derek’s rapid and 
debilitating course with diabetes. Genetic 
predisposition has unarguably contributed to 
Derek’s condition as have many social 
predisposing factors. It is argued that the 
high food costs in northern communities 
may be one such social determinant of 
health. How does the cost of food in Derek’s 
isolated community compare to that in the 
nearest regional centre?  
The financial burden of eating well 
in Derek’s community was documented by 
the present author during August of 2008 at 
one of the two local grocers, the Northern 
store. It was found that it costs a person 
about 2 times as much to stock his or her 
fridge and pantry as someone living in Sioux 
Lookout. Figure 2 shows that by food 
group, most everything is double the price, 
be it processed foods like fries and pizza 
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pops or fresh vegetables, whole grain breads 
and 
milk
 
Figure 2. The number of times groceries are more expensive in Derek’s community in 
comparison to Sioux Lookout by food group.  
This food price comparison is a look 
at August food availability only and in other 
months, supply may be less due to less food 
being available in the off seasons or more 
due to it being less expensive to bring in 
food by ice road during the winter. It was 
found that many fresh and healthy foods 
were available for sale in town; physical 
availability does not seem to be the cause of 
poor diet. If expense were the main barrier 
to eating a healthy and balanced diet then 
price subsidization would be the answer to 
preventing diabetes morbidity. It is likely 
naïve, however, to deem that this would 
resolve the problem. Skeptical of this 
solution, I ponder the following questions, 
“Is it not reasonable to assume that the lower 
cost of living enjoyed by First Nations 
people on reserves should off-set the high 
cost of food? Are people making poor 
choices in terms of how to prioritize their 
financial resources rendering their diets 
inadequate while fulfilling other desires?” 
The reality of the price disparity 
between the north and south cannot be 
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dismissed but I suspect it does not entirely 
explain the high burden of diabetes and its 
comorbidities. Interventions which have set 
out to educate First Nations people on how 
and why one must eat a balanced diet and 
get adequate exercise have shown promise at 
reducing the burden of obesity and diabetes3. 
Perhaps these ingredients for health are met 
with apathy stemming from complex social 
issues including normalization of obesity4, 
boredom, poverty, rebellion, and as Rock, 
M. writes about, distress and societal 
suffering?5 
Investigation into the following 
questions may shed further light on what 
impairs some persons with diabetes from 
maintaining low blood glucose: “What foods 
do you usually buy at the grocery store? 
What percentage of your money do you 
spend on groceries each week? How many 
dependents do you care for and how old are 
they? What is the body mass index (BMI) of 
your dependents? Do you think that healthy 
foods at the store are too expensive? Do you 
know the elements of a balanced diet?” Ho 
et al. asked similar questions and concluded 
that “Increasing knowledge and outcome 
expectations about healthier food 
preparation and selection could help reduce 
fat and sugar intake as well as increase fiber 
intake.”6 
The present discussion leaves many 
questions in terms of the social 
determinants, which led to Derek’s 
condition. However, the case does give 
striking support to the research on the 
debilitating consequences of poorly 
controlled diabetes7, particularly in 
genetically susceptible individuals8. 
Whether or not the cost of groceries in 
Derek’s community prohibited him from 
following dietetic counsel is not known. 
However, it is reasonable to conclude that 
First Nations people in isolated communities 
in Northwestern Ontario must allocate more 
money for groceries than those in the south. 
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to protect Derek’s identity). 
Program: Medicine 5010 Non Credit 
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Balloon brachytherapy in the treatment of invasive 
ductal carcinoma of the breast in a rural setting 
 
Kevin Mitchell, Hon. BSc (Meds 2011) and Valerie Jefford, MD 
 
Case 
A pleasant 61-year-old woman 
presented to her family doctor after her 
good friend was diagnosed with breast 
cancer. She suffers from hypertension 
and Raynaud’s, but denies any 
cardiovascular disease or diabetes. At 
the time of her surgical consultation, she 
was taking Diovan 80/12.5mg, Adalat 
30mg XL, and ASA 80mg OD. The 
patient had an aunt who was diagnosed 
with breast cancer in her sixties, with no 
other significant family history. The 
patient was morbidly obese, but 
otherwise had an unremarkable physical 
exam with the exception of a small 
palpable lump in the lower outer 
quadrant of the right breast, which was 
firm and mobile. No lymphadenopathy 
was detected. She underwent her first 
mammogram, serving as her baseline 
mammogram, and a small abnormality 
was detected in the inferolateral aspect 
of the right breast (Figure 1). A follow-
up ultrasound and biopsy were 
performed (Figure 2). Histological 
examination of the biopsied tissue 
indicated that the patient had invasive 
ductal carcinoma of the right breast.  
 
 
Figure 1. Mammogram of the right breast.  White arrow indicates tumour location. 
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Figure 2. Ultrasound of the right breast. White arrow indicates lesion. 
 
 
The patient was counselled 
regarding her surgical options. She was 
offered a right partial mastectomy 
followed by radiation treatment, or a 
total mastectomy. She was also informed 
about the sentinel lymph node biopsy 
procedure, as well as the axillary lymph 
node biopsy that may be necessary if the 
sentinel lymph node biopsy was positive 
for metastasis. The patient was also 
educated on the sequence of events 
following surgery, including some 
routine investigations and a referral to 
medical radiation oncology. The patient 
decided to proceed with a partial 
mastectomy, understanding that 
radiation treatment must follow surgery. 
 
The surgery was performed and the 
tumour was determined to be 1.5 
centimetres in diameter with a Grade I 
Nottingham score. Sentinel lymph node 
biopsy showed no metastasis.  The 
distance of the closest margin of the 
tumour was less than 1mm from normal 
tissue, so the anterior margin was re-
excised a few days later as a cautionary 
measure. The final pathology report 
showed fibrofatty tissue with a few small 
ducts and one larger duct with 
hyperplastic epithelium. Also present 
were small clusters and tubules of bland 
atypical cells. Haematoxylin and Eosin 
stains were performed, as well as 
Immunoperoxidase stains. The results 
were compatible with low grade invasive 
carcinoma of mammary ductal origin. 
 
As an alternative to whole breast 
radiation, the patient was informed of 
balloon brachytherapy using a 
MammoSite balloon catheter. The 
patient opted to undergo this procedure, 
which entailed implanting a silicone 
balloon connected to a catheter with an 
inflation channel and a port for the 
insertion of a high-dose brachytherapy 
source. Radiation treatment for this type 
of procedure generally consists of an 
192Ir source connected to a computer-
controlled high-dose-rate remote 
afterloader being inserted into the 
balloon to deliver the prescribed dose of 
radiation.1 The balloon catheter was 
implanted into the patient and was 
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inflated to its maximum capacity of 
70mL with normal saline (Figure 3). The 
surgery was performed at Western 
Memorial Regional Hospital in Corner 
Brook, Newfoundland, after which the 
patient was transferred to the Health 
Sciences Centre in St. John’s, 
Newfoundland to receive a 5-day course 
of radiation. 
 
 
Figure 3. Post-operative CT scan of 
right breast. White arrow indicates 
brachytherapy balloon filled with normal 
saline. 
 
Discussion 
 
Breast conservation therapy (BCT) 
is an attractive treatment option for 
patients with Stage I and II breast 
cancer.2 BCT for early-stage breast 
cancer involves the surgical removal of 
the tumour followed by whole-breast 
radiation.3 Long-term studies have 
indicated that disease-free survival for 
breast conservation therapy is similar 
when compared to mastectomy.4,5 Based 
on the cosmetic advantages and the 
similar survival rates, balloon 
brachytherapy is an ideal treatment 
option for patients wishing to avoid a 
total mastectomy. 
 
Patient selection criteria for 
balloon brachytherapy as determined by 
the American Society of Breast Surgeons 
is patient age of 50 years or over, 
invasive ductal carcinoma or ductal 
carcinoma in situ, 2 cm tumour size, 
negative microscopic margins with 
surgical margins of excision of at least 2 
mm, and N0 nodal status.1 
 
In comparison to multi-catheter 
brachytherapy, balloon brachytherapy 
has several advantages. Balloon 
brachytherapy has been shown to be 
superior to interstitial high-dose 
radiation brachytherapy in planning 
target volume coverage.6 While both 
therapies deliver high-dose radiation to 
the patient in one week or less, 
interstitial implants using multiple 
catheters require additional expertise and 
training. Furthermore, numerous 
puncture sites are required for multi-
catheter brachytherapy, which can lead 
to suboptimal cosmetic outcome and 
infection.1  
 
Balloon brachytherapy confines 
radiation treatment to a limited volume 
of breast tissue adjacent to the 
lumpectomy cavity, which allows for a 
higher dose of radiation per fraction, 
decreasing treatment time.6 This makes 
balloon brachytherapy an ideal treatment 
option for patients from smaller 
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communities. Conventional radiation 
therapy following lumpectomy generally 
takes 5 weeks to complete. For a patient 
from a small town, this requires 
undergoing daily radiation treatments in 
a larger centre, potentially far away from 
the patient’s place of residence. The 
patient treated in this case resided over 
600 km from the closest breast cancer 
radiation treatment centre. Balloon 
brachytherapy enabled the patient to 
undergo a 5-day course of radiation 
treatment as an alternative to 5 weeks of 
radiation. In the context of the patient’s 
illness experience, instead of having to 
relocate to St. John’s, Newfoundland for 
5 weeks, the patient was able to stay in 
St. John’s for 5 days to complete her 
radiation treatment and then return 
home. Ultimately, this treatment option 
allows for less time away from home and 
a higher quality of life during treatment.  
 
Conclusion 
 
 BCT with balloon brachytherapy 
is an excellent treatment option for 
patients fitting the selection criteria. This 
therapy has very good cosmetic results 
along with a reduced post-operative 
radiation treatment time while 
maintaining the efficacy of a total 
mastectomy. This allows for patients to 
receive treatment while limiting the 
interference in their everyday lives that 
comes with 5-week whole-breast 
radiation courses, resulting in an 
increased quality of life. Where patients 
from rural communities once may have 
chosen a total mastectomy instead of 
undergoing BCT due to the five weeks 
of radiation, balloon brachytherapy and 
the associated reduced treatment time 
enables these patients to opt for BCT in 
lieu of a total mastectomy. 
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Peripheral Vascular Disease: A Tale of Ulcers and Cans of 
Tomatoes 
Laura Hinz BSc (Meds 2011), Dr. Laura Heemskerk, MD and Dr. Ernie Janzen, MD 
Case  
This is a case of peripheral vascular 
disease, but it is not a story about a toe.  
Rather, it is a story about a can of tomatoes.  
A can that is perched precariously on the 
counter in the home of a 92-year old woman, 
Mrs. S.  Six months ago, that can fell onto 
the first toe of her left foot.  Five months 
ago, Mrs. S began to experience increasing 
discomfort in that toe and began a home 
treatment regimen of Polysporin (bacitracin 
and polymyxin) and Bactroban. 
Mrs. S is accustomed to managing 
her own health concerns, as she is currently 
on medication for hypothyroidism 
(Synthroid), hypertension (Adalat and 
Inhibace) and atrial fibrillation (Coumadin).  
She has peripheral vascular disease that was 
treated with bilateral surgical 
revascularization twenty years ago yet she 
has absent popliteal and pedal pulses.  Her 
medical history was notable for migraines, 
angina, varicosities, macular degeneration, 
and profound hearing loss in the left ear. 
When it became clear that her home 
treatments were making slow progress, Mrs. 
S presented to her internist’s office.  The can 
of tomatoes had done considerable damage- 
the sole of the left great hallux was marked 
by a 1.5 cm ulceration that extended to the 
bone.  There was no necrosis or obvious 
signs of infection except a slight yellow 
drainage.  Mrs. S needed to wear her shoes 
at all times in order to maintain her balance- 
meaning the wound was under constant 
pressure. 
The internist informed Mrs. S that in 
order to prevent amputation of the toe and 
possibly the foot, she would need to be 
admitted to hospital, a treatment plan that 
was less than appealing to Mrs. S.  She had a 
home and a dog to care for and was reluctant 
to relinquish her independence, yet she 
eventually consented to enter the hospital.  
The wound was diagnosed as an ischaemic 
ulcer secondary to peripheral vascular 
disease and a plastic surgery consult was 
ordered.  The x-ray revealed no fractures or 
dislocations but significant vascular 
calcification between the first and second 
metatarsals.   She was treated with a silver 
sulfadiazine dressing (Flamazine), 
Amoxicillin and Clavulin orally.  Mrs. S 
spent 27 days in hospital and was discharged 
with forefoot offloading shoes. 
Peripheral Vascular Disease: 
Manifestations 
Peripheral vascular disease is an 
occlusive disorder caused by atherosclerosis. 
More than 50% of patients are asymptomatic 
whereas others present with claudication, 
ischaemic ulcers, or gangrene when blood 
supply is unable to meet metabolic demand 
(Figure 1).1,2 PVD is more common in the 
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elderly, with a 5.6% prevalence in the 38-59 
age range versus 26% in those 81 and older.1  
A study in Wound Repair and Regeneration 
found that 26.2% of patients admitted from 
nursing homes had pressure ulcers compared 
to only 4.8% from other living situations.3  
Ulcers are especially prevalent among 
patients with diabetes mellitus, with up to 
25% of diabetics developing an ulcer.4  Risk 
factors for PVD include smoking, 
hypothyroidism, diabetes, hypertension, 
dyslipidemia, elevated plasma 
homocysteine.1  Besides endangering the 
viability of peripheral tissue, PVD can also 
increase the risk of adverse cardiovascular 
events such as MI or stroke.1 
PVD most often manifests as leg 
ulcers, which can be classified as arterial, 
venous, or neuropathic:5
 
 
  Figure 1.  Comparison of the manifestations of leg ulcers in terms of location, colour of wound, 
presence of pain/pulse/sensation, and subclassification.1,2  
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PVD: Diagnosis 
 The single most useful tool in 
assessing the manifestations of PVD, 
according to the Ontario Venous Leg Ulcer 
Community Care Protocol, is the ankle-
brachial pressure index (ABPI), a ratio of 
the blood pressure in the arm relative to the 
leg.6  Normal ABPI is 0.9 to 1.2,  venous 
ulcers have an ABPI greater than 0.8, mixed 
ulcers between 0.5 and 0.8 and arterial 
ulcers less than 0.5.6,1  This distinction 
determines management as arterial ulcers 
often require referral to a vascular specialist 
while venous ulcers may be treated with 
compression bandages and topical 
antibiotics.6  Also helpful in the diagnosis of 
PVD are segmental Doppler pressures, 
volume plethysmography, duplex imaging, 
magnetic resonance angiography, and 
contrast angiography.5 
 As in the case of Mrs. S, the 
manifestations are easy to diagnose once 
they are observed but the challenge is often 
the identification step.  Despite frequent 
access to quality care, ulcers may go 
unnoticed for a myriad of reasons- they are 
overshadowed by more pressing health 
concerns or they are unnoticed even by the 
patient (such as in cases of diabetic 
neuropathy).  In a study of patients receiving 
home health care, 7-12% had pressure 
ulcers.7  This study recommended an 
educational program for home healthcare 
workers in order to promote early 
recognition of ulcers. 
 
 
PVD: Treatment 
 To promote healing, the ulcerated 
area must be offloaded.  This can be 
achieved through footwear modification or 
activity restriction.8  The challenge is to 
remove pressure from the wound without 
compromising balance.  Options for 
footwear modification include insoles 
(Sorbothane or polyurethane), plantar 
moulding, forefoot offloading shoes, and 
rocker bottom shoes.  However these 
modifications have been shown to reduce 
activity level by up to 90%.8   
 Treatment of leg ulcers often 
involves topical or oral antibiotics with more 
severe cases requiring amputation.  
Treatment of PVD focuses on control of risk 
factors- smoking cessation, diabetic control, 
statins for dyslipidemia, antiplatelet therapy, 
ACE inhibitors, and exercise.1 
Discussion 
 The diagnosis and treatment in this 
case was fairly straight forward- a known 
history of peripheral vascular disease, a clear 
mechanism of injury, recognition of the need 
to remove sources of pressure to promote 
healing and the use of antibiotics to prevent 
infection.  The unique features of the case 
pertain to the can of tomatoes.   
 Two immediate questions are why 
the injury occurred in the first place and why 
it went untreated for six months.  The 
answer to the first question may be 
attributed to advances in internal medicine.  
According to Dr. Hazel, a plastic surgeon in 
Lethbridge, Alberta, “internal medicine has 
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become too good- people no longer die of 
their organ problems; now we have to be 
aware of peripheral issues.”  In the USA, 
60,000 patients die of peripheral ulcer 
complications annually.7  Mrs. S had a past 
history riddled with internal complaints but 
all were well controlled with medication, 
thus allowing her to remain in her own home 
at the age of 92.  So while the internists may 
congratulate themselves on the arsenal of 
effective medications at their disposal, they 
must be aware of the new Frankenstein their 
success has created.  Increasing attention 
must be paid to issues outside of the head 
and thorax.  The Ontario Leg Ulcer 
Community Care Protocol suggests that 
monitoring is the single best intervention in 
regards to peripheral ulcers.9  Simple tests 
such as the ankle-brachial index are quick 
and easy to complete at each visit and when 
combined with a physical exam that extends 
to each digit may lead to earlier diagnosis of 
arterial ulcers.  Care of PVD and subsequent 
ulcers requires a multidisciplinary 
approach.10 
 The response to the second question 
is twofold- the ulcer was not noted because 
Mrs. S’s caretakers and physicians did not 
see it and because she chose not to display 
it.  Why did she choose to conceal a bone-
depth ulceration?  It is likely because she 
knew that in hospital tomatoes came not in 
cans, but only in the plastic compartment of 
her meal tray.  The can represented her 
independence, her ability to care for herself.  
This is in contrast to what Morgan and 
Moffatt described as the “social ulcer”- a 
wound that the patient hopes will not heal in 
order to maintain contact with the medical 
profession and thus the outside world.11  The 
complication in this case was not the 
diagnosis or treatment of the ulcer, but the 
struggle of an elderly woman to choose 
between staying in a place where tomatoes 
came in cans and entering a place that would 
promote the viability of her toe.  A study in 
International Wound Care identified 
practitioner focus on the wound rather than 
the whole person as one of the greatest 
barriers to ulcer care.11 
 Struggles such as this take time to 
contemplate- time that most internists do not 
have.  Enter the medical student.  We often 
worry that we don’t have the knowledge or 
experience to effectively treat patients.12  
But we are also lacking something else that 
serves in our favour- pagers.  A medical 
student is at liberty to spend an hour with 
patients like Mrs. S, working out details 
such as who would care for her dog.2  So the 
next time you feel under qualified or 
obtrusive as a medical student, remember 
that both the physician and the patient will 
be grateful for your pager-less ability to 
acknowledge the importance of the can of 
tomatoes, not just the ulcer. 
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Coronary Artery Disease: Medical Management vs. 
Percutaneous Coronary Intervention 
 
Samir Raza, BESc Candidate (Meds 2010) and Jaffer Syed, MD, FRCP 
 
Case 
 
Mrs.G, a 55 year old female, 
presented to her family doctor one year 
ago with chest pain on exertion. The 
pain was described as sharp in nature, 
radiating to both arms and was not 
accompanied by shortness of breath. 
Symptoms initially appeared following 
weight lifting at the gym. Currently, she 
is able to carry out all activities of daily 
living (ADLs) without limitation. Chest 
pain is elicited by brisk walking or 
carrying groceries up stairs, placing her 
in Canadian Cardiovascular Society 
(CCS) class I-II. She has a blood 
pressure of 130/72, heart rate of 60, and 
BMI of 27. She is a non-smoker with 
well controlled dyslipidemia. Upon 
investigation, MIBI stress testing 
demonstrated moderate-sized inferior 
wall ischaemia consistent with right 
coronary artery (RCA) disease. Her 
current medications include ECASA, 
atorvastatin, ezetimibe (antilipemic), 
bisprolol (beta-blocker), perindopril 
(ACE inhibitor), and a nitroglycerine 
spray. Following discussion with the 
patient, it was decided that coronary 
angiography and possible percutaneous 
coronary intervention (PCI) was not 
indicated at this time as symptoms were 
mild and a satisfactory quality of life 
was maintained. Mrs.G was encouraged  
 
 
 
 
to use her nitroglycerine spray 
prophylactically. 
 
Discussion 
 
Coronary Artery disease (CAD) is 
the leading cause of death in the 
developed world with 1/3 of all deaths 
attributed to CAD1. Blood flow through 
the coronary arteries becomes impaired 
by two mechanisms: 
 
1. Stenotic lesions 
2. Endothelial dysfunction 
 
Fixed atherosclerotic plaques cause a 
narrowing of the coronary arteries. This 
stenosis causes an increase in vascular 
resistance and thus, a decrease in 
coronary blood flow. Atherosclerotic 
plaques may also be associated with 
endothelial dysfunction and paradoxical 
coronary vasoconstriction. During times 
of physical or emotional stress, a 
mismatch in myocardial oxygen supply 
and demand (myocardial ischemia) may 
result from both epicardial stenosis and 
endothelial dysfunction. Myocardial 
ischemia often (but not universally) 
manifests clinically as angina pectoris 2. 
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Signs and Symptoms 
 
Angina pectoris is the hallmark 
symptom of CAD. It is frequently 
described by patients as a diffuse 
retrosternal tightness or pressure in the 
chest lasting for a few minutes. In 
women it is not uncommon for the pain 
to be described as sharp. It commonly 
radiates to the shoulders and arms. 
Patients often hold a clenched fist over 
their chest to describe the pain, this is 
known as “Levine’s sign”. Anginal 
symptoms are elicited by 
physical/emotional stress, eating, and 
exposure to cold3. 
 
Diagnosis 
  
In addition to the clinical findings 
mentioned, there are a variety of tests 
available to aid in the diagnosis of CAD. 
Table 1 lists the different modalities. 
 
Table 1. Diagnostic studies and corresponding 
positive findings for CAD4. 
Modality Finding 
ECG / Exercise 
Stress Test ST depression, T wave inversion 
Nuclear studies 
(MIBI scan) 
Poor radionuclide accumulation in 
ischemic areas. Radionuclide 
accumulates in proportion to 
degree of perfusion of viable 
myocardial cells. 
Exercise 
Echocardiography 
Stress-induced regional wall-
motion abnormality 
Coronary 
Angiography 
Stenotic coronary artery seen on 
fluoroscopy during injection of 
contrast agent 
 
CAD can lead to and/or exacerbate 
heart failure. The New York Heart 
Association (NYHA) Functional 
Classification system is commonly used 
to classify the severity of heart failure.  
This classification system is based upon 
the degree of physical limitation 
experienced by the patient. Table 2 lists 
the NYHA system5. 
 
Table 2. NYHA Functional Classification 
system for heart failure5. 
Class Definition 
I 
Patients with no limitation of 
activities; they suffer no symptoms 
from ordinary activities 
II 
Patients with slight, mild limitation of 
activity, they are comfortable with rest 
or mild exertion 
III 
Patients with marked limitation of 
activity; they are comfortable only at 
rest 
IV 
Patients who should be at complete 
rest, confined to bed or chair; any 
physical activity brings discomfort and 
symptoms occur at rest 
 
Medical Management  vs. PCI 
 
Treatment of CAD involves medical 
management to control symptoms of 
ischemia as well as control of coronary 
risk factors, and occasionally 
revascularization (PCI or CABG). The 
goals of treatment are threefold: 
 
1. Decrease frequency and severity 
of anginal episodes 
2. Prevent myocardial infarction 
3. Prolong survival 
 
Medical management of ischemic 
symptoms of CAD often involves a 
combination of three anti-ischemic 
medications: nitrates, beta blockers, and 
calcium channel blockers4. Nitrates are 
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primarily used prophylactically and as 
needed for acute symptom relief.  For 
secondary prevention purposes, ASA, 
statins, and ACE-inhibitors or 
angiotensin-receptor blockers (ARB) are 
strongly recommended. 
 
Revascularization involves either 
percutaneous coronary intervention 
(PCI) or coronary artery bypass grafting 
(CABG). Traditionally, PCI has been 
indicated for discrete single or double 
vessel disease whereas CABG has been 
the mainstay of treatment for left-main 
or multi-vessel disease6. However, 
advances in interventional techniques 
and the advent of drug eluting stents 
have resulted in increasing numbers of 
patients with complex, multi-vessel and 
left main disease being treated via PCI7.  
Current literature suggests that PCI in 
stable CAD offers improved symptom 
relief as compared to medical therapy 
alone, but it does not prolong survival8.  
In the case of Mrs.G, her nuclear MIBI 
findings suggested single vessel CAD, 
and PCI could potentially be appropriate 
for relief of unacceptable symptoms. 
However, given the additional risks 
associated with any invasive procedure, 
angiography and revascularization 
(CABG or PCI) is generally indicated in 
only three situations: 
 
1. Medical therapy has not 
adequately improved patient’s 
symptoms 
2. Unacceptable adverse effects 
associated with medication 
3. Patients who are suspected to 
have high-risk CAD4 
 
The cornerstone of management of 
CAD is aggressive medical therapy.  
When this fails, or non-invasive testing 
suggests a high-risk pattern of CAD, 
coronary angiography is indicated.  
Angiographic findings, patient age, co-
morbidities, and patient preferences, are 
some main factors considered when 
deciding upon the appropriate route of 
revascularization. 
 
Conclusion 
 
Mrs.G presented with a one year 
history of chronic stable angina. 
Symptoms were well-controlled on 
medical therapy alone, and non-invasive 
testing did not suggest a prognostically 
significant pattern of CAD.  Based on 
these considerations, continuance of 
medical therapy was recommended. 
Prophylactic use of nitroglycerin spray 
was encouraged, as was continued 
coronary risk factor reduction. 
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Adolescent hallux valgus; a novel case report and 
review 
Anthony Main, BSc (Meds 2011) and Peter Clark, MD, FRCSC 
 
Case 
 
A 12-year-old female presented 
with a four year history of bilateral 
hallux valgus (HV) which caused her no 
pain, but a significant cosmetic 
deformity as seen in figure 1.  Her 
condition had been treated 
conservatively by a podiatrist for 4 years 
with splinting, toe gel spacers, and use 
of anti-pronation running shoes.  
However, her HV deformity showed no 
improvement with conservative 
management.  Her parents, concerned 
that the deformity would become more 
severe over time, consulted their family 
physician, who arranged for 
radiographic imaging studies and 
referred her for an orthopedic consult for 
surgical management. 
 
Figure 1. Juvenile hallux valgus deformity of right foot in an asymptomatic 12-year-old 
girl.  Deformity is bilateral with a second hallux valgus deformity on the left foot. 
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On examination, the patient was 
found to have a 20° HV angle pes planus 
and short first metatarsal.  Her medical 
history was non-contributory.  She was 
born at term by cesarean section and had 
a fraternal twin brother.   
 
 Bilateral foot radiographic 
examination was undertaken with AP, 
lateral and oblique views of the patients 
foot.  The patient was found to be 
skeletally immature with open physes, 
and the HV deformity was worse on the 
right than the left.  Radiographs also 
revealed a congenitally short first 
metatarsal, HV angle of 20° and an 
abnormal metatarsophalangeal (MTP) 
joint which was cone shaped with a ring 
shaped epiphysis at the base of the 
proximal phalanx, as seen in Figures 2 
and 3.  To our knowledge, this joint 
pattern is a unique presentation of 
adolescent HV and has not been reported 
in the literature. 
 
Figure 2. AP bilateral radiograph of hallux valgus deformity showing unique cone-in-cup 
MTP joint deformity. 
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As the patient was asymptomatic 
and experiencing no pain, conservative 
treatment of observation and follow up 
were arranged. 
 
Figure 3. Oblique view of bilateral radiograph of hallux valgus deformity showing 
unique cone-in-cup MTP joint deformity. 
 
Discussion 
 
 Adolescent hallux valgus, 
associated with a bunion, is a lateral 
deviation of the great toe in the 
transverse plane of the MTP joint.  It 
generally affects females twice as often 
as males, and incidence varies depending 
on the population being studied and 
cultural practices, such as footwear use.1 
HV has a multifactorial etiology 
including causes such as inflammatory 
joint disease, genetic predisposition, 
abnormal mechanics or anatomy of the 
metatarsophalangeal (MTP) joint or the 
first ray.  It has been proposed that HV is 
caused by poor footwear.  Footwear is 
thought to be an aggravating factor 
rather than a causal factor as not all 
individuals who wear poor footwear go 
on to develop HV.2   
 
 Adolescent HV can be a serious 
finding as it can indicate fibrodysplasia 
ossificans progressiva (FOP), when 
found in combination with short thumbs.  
FOP is a very rare yet deleterious 
genetic disease characterized by 
extraskeletal bone formation.  Pressure 
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on soft tissue causes new born formation 
and can lead to a ‘stone statue’ disease, 
where an individual slowly loses muscle 
function and freezes into one position.3,4 
 
Adolescent HV is thought to be 
caused by metatarsus primus varus 
(MPV).  Taken together, HV and MPV 
are the most common foot deformities in 
adolescents.  As many as 50% of 
adolescent HV patients will also have 
flexible flat feet and ligamentous laxity.3  
 
Diagnosis of HV can be made 
from patient history and clinical 
examination, but may require 
radiographic studies, especially to assess 
the articulating surfaces of the MTP joint 
and for surgical planning.  Physical 
findings associated with HV include 
bursitis of the MTP joint covering, 
synovitis of the MTP joint, hammertoe 
deformity of the lesser toe, medial dorsal 
cutaneous nerve entrapment also known 
as Morton’s neuroma, callus formation 
under the second metatarsal head due to 
altered weight-bearing and the 
development of osteoarthritis of the 
MTP joint.5,6,7  
There are a number of 
radiographic criteria used to assess the 
degree of HV.  First, the status and 
condition of the articulating surfaces of 
the MTP joint should be inspected.  
Second, the HV angle, which is the 
angle made between the articulating 
surfaces of the metatarsal and the 
proximal phalanx should be measured.  
An angle greater than 20° is considered 
abnormal.  Thirdly, the intermetatarsal 
(IMT) angle, which is the angle between 
the first and second metatarsal bones 
should normally be less than 9°.8  
 
Multiple treatment options exist 
for HV and choice depends on the 
amount of discomfort expressed by the 
patient, need for joint salvage and 
physician preference.  There is also great 
debate on whether bilateral or unilateral 
repair is best, and whether joint fusion or 
bunion excision is best.9,10  
 
Conclusion 
 
 We have presented a novel 
description of an adolescent hallux 
valgus in a 12 year old girl and review of 
current hallux valgus literature. 
 
Conservative management of HV 
can include wearing of wide shoes, 
stretching, icing after activity, and 
NSAID medications.  Foot orthoses have 
been used to prevent joint dysfunction 
and relieve pain.  In one study of 
rheumatoid arthritis (RA) patients, 
orthoses were shown to prevent 
progression of the hallux valgus angle in 
90% of the treatment group vs. 75% of 
the control group, however there was no 
significant difference in pain 
experienced.11 Splinting is also used to 
treat HV, most commonly non-weight 
bearing night splints, however a clinical 
trial that examined the effects of splints 
on HV was not able to demonstrate any 
improvements in reducing pain.12   
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Surgical management is based 
upon clinical and radiographic findings.  
A surgeon must take into account a 
patient’s level of pain and ability to 
ambulate before they decide to proceed 
with any surgery.  There are well over 
one hundred different operations 
available to treat HV, but all procedures 
include some combination of the 
following.  Arthrodesis is a surgery 
where the MTP joint is fused resulting in 
loss of ROM but also decrease in pain 
symptoms.  Osteotomy with distal soft 
tissue correction, where the metatarsal 
bone is cut and realigned, is the most 
common surgical option.  In some cases, 
excision of the bunion with soft tissue 
correction is the only operation 
necessary.  In rare cases, a primary joint 
fusion of the MTP joint is required. In 
adolescent hallux valgus, the periosteum 
is very active and the osteotomies 
remodel very well.  The choice of 
surgery depends on degree of angulation 
on radiograph, the status of the 
articulating surface and the patients’ 
symptomatology. 
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Cavitating pulmonary lesions and hemoptysis in a case of 
Wegener’s granulomatosis 
 
Wang Xi, BMSc (Meds 2011) and Louise Moist, MSc, MD, FRCPC 
 
Case 
 
A 49-year old gentleman was 
admitted for investigation of multiple 
cavitating pulmonary lesions on CT and 
hemoptysis (Figure 1)1. He developed a dry, 
non-productive cough a month prior to 
admission with fevers, chills, and night 
sweats, but no shortness of breath and no 
chest pain. Half a month prior to admission, 
he was diagnosed with pneumonia by chest 
X-ray and prescribed azithromycin. Without 
symptomatic relief after one week on 
antibiotics, his treatment regimen was 
changed to gatifloxacin and metronidazole 
for ten days. Three days later, the patient’s 
symptoms worsened to include a productive 
cough yielding yellow sputum, hemoptysis, 
muscle aches, epistaxis, and hematuria. He 
had also lost ten pounds the preceding 
month. The patient was deteriorating which 
prompted CT investigation showing multiple 
cavitation lesions. 
 
The patient had quit smoking three 
years ago after a 30 pack-year history. He 
had an unremarkable medical history, and 
no family history of lung disease or 
vasculitis. He had no known previous 
exposures to farming, mining, or tending to 
birds. He had no significant travel history or 
exposure to tuberculosis. 
 
Figure 1. Multiple, bilateral 
cavitating lesions on CT (adapted from 
Harrison’s Principles of Internal 
Medicine)1. 
 
On examination, the patient had a 
temperature of 38.9oC, a heart rate of 110 
beats/min, blood pressure 127/72, and a 
respiratory rate of 16/minute, saturating 92-
94% oxygen on room air. Examinations of 
cardiovascular and pulmonary systems were 
unremarkable. No finger clubbing was 
present. His hemoglobin was low at 89 g/L 
and creatinine high at 132 µmol/L. 
Urinalysis was positive for blood and 
protein, but negative for casts. Bacterial and 
fungal cultures were requested, as well as an 
initial vasculitis screen with serum ANA, 
rheumatoid factor, C-ANCA, P-ANCA, C3, 
C4, CH50, ESR, and CRP. The C-ANCA 
titre (Proteinase 3, PR3) was positive at 154 
(> 30), strongly suggesting a diagnosis of 
Wegener’s granulomatosis (WG). He was 
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started on pulse prednisone and oral 
cyclophosphamide. 
 
While in hospital, his renal function 
declined, with his creatinine rising to over 
600 µmol/L. A trial of plasma exchange was 
initiated with five treatments over ten days. 
Renal function improved and he was 
fortunate to avoid hemodialysis. Hemoptysis 
and hematuria improved with time. No renal 
biopsy was performed. He was started on 
oral Septra as prophylaxis against 
Pneumocystis carinii pneumonia and also 
given a no-salt-added diet. He was 
discharged 1 month after admission after he 
became stable. At discharge, his hemoglobin 
was low at 93 g/L and creatinine high at 407 
µmol/L. He was to be reassessed and 
advised not to return to work. 
 
Discussion 
 
WG is a systemic vasculitis that is 
characterized by granulomatous lesions in 
the upper and lower respiratory tracts and 
focal necrotizing glomerulonephritis. All of 
the body’s small and medium-sized vessels 
can be affected resulting in many potential 
clinical manifestations (Table 1)2. These 
manifestations may suggest several 
vasculitic etiologies and diagnosis may 
prove to be a challenge. In this case, a 
common presentation of WG is discussed, 
where a supposed pneumonia, as shown on 
chest X-ray, does not resolve after treatment 
with multiple antibiotics. Combined with 
further symptoms and/or investigations, the 
circumstances point toward an alternate 
diagnosis (Table 2)3.  
 
Table 1. Common Clinical Findings of 
Wegener’s Granulomatosis2 
Systemic Fever, lethargy, weakness, 
weight loss, night sweats, skin 
lesions (rash and skin sores), 
arthralgias 
Lungs Pulmonary infiltrates, 
pulmonary nodules, 
hemoptysis, pleuritis 
Kidney Glomerulonephrtitis, 
hematuria, proteinuria 
Ear, Nose, 
Throat 
Sinusitis, nasal membrane 
ulceration and crusting, saddle 
nose deformity, epistaxis, 
hearing loss, ear pain, oral 
lesions 
Eyes Conjunctivitis, eye pain, visual 
loss 
Nervous 
System 
Peripheral neuropathy 
 
The serum auto-immune anti-nuclear 
cytoplasmic antibody (ANCA) level is 
useful in both diagnosis and understanding 
the pathophysiology of WG. Patients with 
active WG are seen to have an auto-immune, 
antigen-dependent, inflammatory 
background, which is corroborated by CD4+ 
T cell and monocyte activation in active 
disease. Next, neutrophils are activated 
through the production of C-ANCA or P-
ANCA by B-cells targeting either Proteinase 
3 (PR3) or Myeloperoxidase (MPO), 
respectively4. However, the ANCAs are 
present in 85% of cases of active WG and 
are not pathognomic for the disease. Other 
ANCA-positive vasculitides are microscopic 
polyangiitis (MPA, 70% positive) and 
Churg-Strauss syndrome (50% positive)4. 
WG is mostly C-ANCA positive while MPA 
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is mostly P-ANCA positive, but this 
differentiation is not clinically significant as 
treatment for both conditions is similar. 
Churg-Strauss presents a different clinical 
picture and generally includes asthma in 
95% of patients, among other atopic allergic 
symptoms5. 
 
Table 2. Typical Differential Diagnosis for 
Hemoptysis with Cavitating Lung Lesions3 
Neoplasms 
Infectious 
  Tuberculosis 
  Histoplasmosis, Aspergillosis, or 
Coccidiomycosis 
  Klebsiella or Staphylococcal pneumonia 
  Lung abcess 
  Septic emboli 
Autoimmune 
  Wegener’s granulomatosis 
  Rheumatoid arthritis 
Environmental exposures 
  Silica 
 
The hypothetical etiology of WG is 
attributed to combinations of infectious, 
genetic, or environmental factors; however, 
efforts in identifying specific factors have 
proved to be difficult6. The disease is 
equally distributed between men and 
women, presenting most commonly among 
the fourth and fifth decades of life7. 
 
The initial presentation of WG may 
be followed by an indolent, mild, or 
aggressive illness. Serum ANCA levels are 
seen to vary with the extent, severity, and 
activity of the disease. A limited form of the 
disease can restrict itself primarily to the 
lungs and is less likely to be ANCA 
positive, but this form may still eventually 
progress to the kidneys8. Poorer survival is 
associated with older age and the need for 
dialysis9. 
 
Treatment of WG has advanced 
greatly since the disease was first described 
in 1936, when 1-year mortality was 100% 
with median survival of 5 months10, 11. 
Treatment with corticosteroids in the 1960s 
procured a median survival time of 8 
months12. The most significant medical 
breakthrough was the introduction of 
cyclophosphamide in the early 1970s that 
prolonged survival and relieved symptoms. 
 
Overall, the treatment plan is two-
fold: to induce remission in patients with 
active WG and to maintain remission once 
the goal has been achieved. The strategy in 
treating WG is primarily immune 
suppression given the inflammatory nature 
of the disease. Patient symptoms, disease 
activity, organ involvement, and lab test 
results are all determinants of a patient’s 
particular treatment plan. In severe WG with 
kidney involvement, cyclophosphamide and 
prednisone are generally prescribed, 
providing symptom relief in 91% of patients 
and inducing remission in 75% of patients2. 
Due to the immunosuppressive nature of 
cyclophosphamide, it is preferred to switch 
to methotrexate or azathioprine after three to 
six months. Induction can be achieved in 
patients with mild disease with methotrexate 
and prednisone. During treatment, 
prophylactic therapy with Septra should be 
used to prevent Pneumocystic carinii 
pneumonia. Septra has also been associated 
with a decreased recurrence of WG. The 
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presence of renal failure in a WG patient 
increases the risk of end-stage renal disease 
and mortality. For patients with creatinine 
over 500 µmol/L, plasma exchange has been 
shown to reduce this risk13.  
 
Even with treatment, WG can recur 
or maintain a low activity level in 60-80% of 
patients, leading to organ damage and 
chronic morbidity2, 14. Important risk factors 
for relapse were C-ANCA positivity and 
disease within the lower or upper respiratory 
tracts15. Overall mortality for WG patients is 
four times the rate of the mortality of the 
general population16. Most (93%) of the 
morbidity and mortality was due to disease-
related activity rather than treatment-related 
causes9. 
 
Table 3. Key Points 
· Wegener’s granulomatosis is a 
complex vasculitis with many 
potential systemic manifestations 
· Suspect alternate etiologies in 
suspected cases of pneumonia that 
does not resolve with multiple 
antibiotics 
· Goals of management are induction 
and maintenance of remission 
· The patient on immunosuppressants 
for WG should be given prophylaxis 
and be vigilant for infections 
· Reduce cardiac risk factors as 
vasculitic diseases increase the risk 
of an adverse cardiovascular event 
 
Conclusion 
 
WG is a systemic vasculitis with 
many potential clinical manifestations and is 
challenging to manage in the clinic. The 
diagnosis of WG has potentially devastating 
impacts on patients’ lives given the high 
risks of organ damage and recurrence of the 
disease. Treatment of WG reduces mortality 
and morbidity but does not eliminate these 
risks altogether. Consequently, patients 
should be given regular follow-up to 
monitor disease remission and organ 
function. 
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